Imipramine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
Imipramine | hsa00040 | Pentose and glucuronate interconversions | 4.00E-02 | 1 | P15121 | AKR1B1 | More | |
Imipramine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
Imipramine | hsa00053 | Ascorbate and aldarate metabolism | 3.63E-04 | 3 | P51648, P14550, Q9UEF7 | ALDH3A2, AKR1A1, KL | More | |
Imipramine | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | |
Imipramine | hsa00190 | Oxidative phosphorylation | 4.07E-05 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | |
Imipramine | hsa00220 | Arginine biosynthesis | 1.97E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | |
Imipramine | hsa00240 | Pyrimidine metabolism | 4.29E-02 | 2 | P21589, P04183 | NT5E, TK1 | More | |
Imipramine | hsa00250 | Alanine, aspartate and glutamate metabolism | 1.97E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | |
Imipramine | hsa00280 | Valine, leucine and isoleucine degradation | 4.55E-02 | 2 | P21953, P51648 | BCKDHB, ALDH3A2 | More | |
Imipramine | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | |
Imipramine | hsa00513 | Various types of N-glycan biosynthesis | 4.96E-02 | 1 | Q9NR34 | MAN1C1 | More | |
Imipramine | hsa00564 | Glycerophospholipid metabolism | 4.29E-02 | 2 | Q6P1A2, P23743 | MBOAT5, DGKA | More | |
Imipramine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
Imipramine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Imipramine | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
Imipramine | hsa00600 | Sphingolipid metabolism | 3.01E-02 | 2 | Q9BX95, P06280 | SGPP1, GLA | More | |
Imipramine | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.87E-03 | 3 | P06865, O15466, Q9H4F1 | HEXA, ST8SIA5, ST6GALNAC4 | More | |
Imipramine | hsa00620 | Pyruvate metabolism | 3.17E-03 | 4 | P40926, P07195, P14550, P11766 | MDH2, LDHB, AKR1A1, ADH5 | More | |
Imipramine | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Imipramine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Imipramine | hsa00790 | Folate biosynthesis | 2.02E-02 | 1 | P15121 | AKR1B1 | More | |
Imipramine | hsa00830 | Retinol metabolism | 3.15E-02 | 1 | P00325 | ADH1B | More | |
Imipramine | hsa00910 | Nitrogen metabolism | 1.97E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | |
Imipramine | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.49E-04 | 3 | O95363, P14868, Q15046 | FARS2, DARS, KARS | More | |
Imipramine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6.38E-04 | 3 | P78417, P09211, P11712 | GSTO1, GSTP1, CYP2C9 | More | |
Imipramine | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Imipramine | hsa00983 | Drug metabolism - other enzymes | 1.70E-04 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | |
Imipramine | hsa01100 | Metabolic pathways | 4.56E-02 | 11 | P15144, P32320, P06280, P24666, P33121, P42330, Q13093, Q9NY28, Q9BX95, P09960, Q16718 | ANPEP, CDA, GLA, ACP1, ACSL1, AKR1C3, PLA2G7, GALNT8, SGPP1, LTA4H, NDUFA5 | More | |
Imipramine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | |
Imipramine | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | |
Imipramine | hsa01240 | Biosynthesis of cofactors | 2.52E-02 | 2 | Q9BQB6, P14550 | VKORC1, AKR1A1 | More | |
Imipramine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 3.18E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Imipramine | hsa01522 | Endocrine resistance | 2.63E-05 | 7 | P14780, P22694, P04049, Q9UM47, P08069, P10415, Q13323 | MMP9, PRKACB, RAF1, NOTCH3, IGF1R, BCL2, BIK | More | |
Imipramine | hsa01523 | Antifolate resistance | 3.80E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | |
Imipramine | hsa02010 | ABC transporters | 1.66E-04 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | |
Imipramine | hsa03010 | Ribosome | 3.40E-09 | 18 | P62753, P42677, P25398, P32969, P40429, P62917, P62829, P46776, Q9H0U6, Q07020, P62910, P18077, Q02878, P36578, P27635, P05386, P62249, P23396 | RPS6, RPS27, RPS12, RPL9, RPL13A, RPL8, RPL23, RPL27A, MRPL18, RPL18, RPL32, RPL35A, RPL6, RPL4, RPL10, RPLP1, RPS16, RPS3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P02768 | ALB | Albumin | P62753 | RPS6 | 40S ribosomal protein S6 | 0.769 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.739 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P42677 | RPS27 | 40S ribosomal protein S27 | 0.834 | P02768 | ALB | Albumin | P25398 | RPS12 | 40S ribosomal protein S12 | 0.775 | P02768 | ALB | Albumin | P32969 | RPL9 | 60S ribosomal protein L9 | 0.795 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P32969 | RPL9 | 60S ribosomal protein L9 | 0.722 | P09211 | GSTP1 | Glutathione S-transferase P | P40429 | RPL13A | 60S ribosomal protein L13a | 0.741 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P40429 | RPL13A | 60S ribosomal protein L13a | 0.825 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P62917 | RPL8 | 60S ribosomal protein L8 | 0.866 | P02768 | ALB | Albumin | P62829 | RPL23 | 60S ribosomal protein L23 | 0.757 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P46776 | RPL27A | 60S ribosomal protein L27a | 0.758 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | Q9H0U6 | MRPL18 | 39S ribosomal protein L18, mitochondrial | 0.831 | P09211 | GSTP1 | Glutathione S-transferase P | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.779 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.802 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P62910 | RPL32 | 60S ribosomal protein L32 | 0.804 | P02768 | ALB | Albumin | P18077 | RPL35A | 60S ribosomal protein L35a | 0.7 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | Q02878 | RPL6 | 60S ribosomal protein L6 | 0.819 | P02768 | ALB | Albumin | P36578 | RPL4 | 60S ribosomal protein L4 | 0.708 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P36578 | RPL4 | 60S ribosomal protein L4 | 0.823 | P09211 | GSTP1 | Glutathione S-transferase P | P27635 | RPL10 | 60S ribosomal protein L10 | 0.772 | P09211 | GSTP1 | Glutathione S-transferase P | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.707 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.881 | P09211 | GSTP1 | Glutathione S-transferase P | P62249 | RPS16 | 40S ribosomal protein S16 | 0.702 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P62249 | RPS16 | 40S ribosomal protein S16 | 0.818 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P23396 | RPS3 | 40S ribosomal protein S3 | 0.886 | P02768 | ALB | Albumin | P62753 | RPS6 | 40S ribosomal protein S6 | 0.769 | P02768 | ALB | Albumin | P25398 | RPS12 | 40S ribosomal protein S12 | 0.775 | P02768 | ALB | Albumin | P32969 | RPL9 | 60S ribosomal protein L9 | 0.795 | P09211 | GSTP1 | Glutathione S-transferase P | P40429 | RPL13A | 60S ribosomal protein L13a | 0.741 | P02768 | ALB | Albumin | P62829 | RPL23 | 60S ribosomal protein L23 | 0.757 | P09211 | GSTP1 | Glutathione S-transferase P | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.779 | P02768 | ALB | Albumin | P18077 | RPL35A | 60S ribosomal protein L35a | 0.7 | P02768 | ALB | Albumin | P36578 | RPL4 | 60S ribosomal protein L4 | 0.708 | P09211 | GSTP1 | Glutathione S-transferase P | P27635 | RPL10 | 60S ribosomal protein L10 | 0.772 | P09211 | GSTP1 | Glutathione S-transferase P | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.707 | P09211 | GSTP1 | Glutathione S-transferase P | P62249 | RPS16 | 40S ribosomal protein S16 | 0.702 |
|
Imipramine | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | |
Imipramine | hsa03020 | RNA polymerase | 2.72E-08 | 5 | P30876, P24928, P62487, Q9GZM3, P52435 | POLR2B, POLR2A, POLR2G, POLR2J2, POLR2J | More | |
Imipramine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | |
Imipramine | hsa03050 | Proteasome | 1.21E-02 | 1 | P28074 | PSMB5 | More | |
Imipramine | hsa03060 | Protein export | 4.46E-03 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | |
Imipramine | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | |
Imipramine | hsa03410 | Base excision repair | 2.52E-02 | 2 | P49005, P29372 | POLD2, MPG | More | |
Imipramine | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | |
Imipramine | hsa04010 | MAPK signaling pathway | 1.69E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Imipramine | hsa04012 | ErbB signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04014 | Ras signaling pathway | 1.30E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Imipramine | hsa04015 | Rap1 signaling pathway | 1.25E-03 | 6 | P04049, P08069, P25116, Q8TEU7, P08514, P17252 | RAF1, IGF1R, F2R, RAPGEF6, ITGA2B, PRKCA | More | |
Imipramine | hsa04022 | cGMP-PKG signaling pathway | 6.45E-03 | 5 | P04049, P18848, Q8WYR1, P05141, P0DP24 | RAF1, ATF4, PIK3R5, SLC25A5, CALM2 | More | |
Imipramine | hsa04024 | cAMP signaling pathway | 2.66E-03 | 5 | P49019, P22694, P20020, P04049, P48058 | HCAR3, PRKACB, ATP2B1, RAF1, GRIA4 | More | |
Imipramine | hsa04062 | Chemokine signaling pathway | 3.98E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Imipramine | hsa04068 | FoxO signaling pathway | 3.80E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Imipramine | hsa04071 | Sphingolipid signaling pathway | 2.69E-07 | 9 | P04049, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | RAF1, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.704 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.935 | P22748 | CA4 | Carbonic anhydrase 4 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.814 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.809 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.787 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.935 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P01375 | TNF | Tumor necrosis factor | 0.871 | P22748 | CA4 | Carbonic anhydrase 4 | P01375 | TNF | Tumor necrosis factor | 0.744 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P01375 | TNF | Tumor necrosis factor | -0.769 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P01375 | TNF | Tumor necrosis factor | 0.871 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.838 | P22748 | CA4 | Carbonic anhydrase 4 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.758 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.712 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.838 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.727 | P22748 | CA4 | Carbonic anhydrase 4 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.88 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.727 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.791 | P22748 | CA4 | Carbonic anhydrase 4 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.863 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.791 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | -0.866 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P08246 | ELA2 | Neutrophil elastase | P17252 | PRKCA | Protein kinase C alpha type | -0.735 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.704 | P08246 | ELA2 | Neutrophil elastase | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.725 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.809 | P08246 | ELA2 | Neutrophil elastase | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.797 | P22748 | CA4 | Carbonic anhydrase 4 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.814 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.787 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P22748 | CA4 | Carbonic anhydrase 4 | P01375 | TNF | Tumor necrosis factor | 0.744 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P01375 | TNF | Tumor necrosis factor | -0.769 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.712 | P08246 | ELA2 | Neutrophil elastase | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.865 | P22748 | CA4 | Carbonic anhydrase 4 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.758 | P08246 | ELA2 | Neutrophil elastase | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.847 | P22748 | CA4 | Carbonic anhydrase 4 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.88 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 | P08246 | ELA2 | Neutrophil elastase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.942 | P22748 | CA4 | Carbonic anhydrase 4 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.863 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | -0.866 |
|
Imipramine | hsa04072 | Phospholipase D signaling pathway | 2.82E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04080 | Neuroactive ligand-receptor interaction | 2.95E-04 | 8 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | |
Imipramine | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | |
Imipramine | hsa04114 | Oocyte meiosis | 1.43E-03 | 6 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0, P08069 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | |
Imipramine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
Imipramine | hsa04137 | Mitophagy - animal | 3.55E-04 | 4 | Q96CV9, Q9H1Y0, P18848, O43524 | OPTN, ATG5, ATF4, FOXO3 | More | |
Imipramine | hsa04140 | Autophagy - animal | 9.64E-03 | 5 | P08069, P04049, P22694, Q14643, P10415 | IGF1R, RAF1, PRKACB, ITPR1, BCL2 | More | |
Imipramine | hsa04141 | Protein processing in endoplasmic reticulum | 1.39E-03 | 8 | P18848, P30101, P49257, O60337, P60604, P11142, P07900, Q9H173 | ATF4, PDIA3, LMAN1, MARH6, UBE2G2, HSPA8, HSP90AA1, SIL1 | More | |
Imipramine | hsa04145 | Phagosome | 2.75E-02 | 4 | Q15080, P14598, P68371, Q13488 | NCF4, NCF1, TUBB2C, TCIRG1 | More | |
Imipramine | hsa04146 | Peroxisome | 3.03E-04 | 6 | O43933, O96011, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX11B, PEX3, CROT, ECI2, ACSL1 | More | |
Imipramine | hsa04150 | mTOR signaling pathway | 5.20E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | |
Imipramine | hsa04151 | PI3K-Akt signaling pathway | 1.24E-03 | 15 | P62753, P43657, O43521, P27348, P09603, Q9GZP0, Q8WYR1, P63218, P50151, P13612, O15335, Q13751, P18848, O00141, Q6ZUJ8 | RPS6, P2RY5, BCL2L11, YWHAQ, CSF1, PDGFD, PIK3R5, GNG5, GNG10, ITGA4, CHAD, LAMB3, ATF4, SGK, PIK3AP1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.709 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.724 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P27348 | YWHAQ | 14-3-3 protein theta | 0.708 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9GZP0 | PDGFD | Platelet-derived growth factor D | 0.736 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.76 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.844 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.902 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P13612 | ITGA4 | Integrin alpha-4 | 0.77 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15335 | CHAD | Chondroadherin | -0.729 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.794 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.755 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.728 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.709 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.724 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P27348 | YWHAQ | 14-3-3 protein theta | 0.708 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9GZP0 | PDGFD | Platelet-derived growth factor D | 0.736 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.76 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.844 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.902 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P13612 | ITGA4 | Integrin alpha-4 | 0.77 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15335 | CHAD | Chondroadherin | -0.729 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.794 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.755 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.728 |
|
Imipramine | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Imipramine | hsa04210 | Apoptosis | 6.94E-04 | 8 | O76075, P01375, Q9NR28, O75460, Q16548, O43521, P18848, P04049 | DFFB, TNF, DIABLO, ERN1, BCL2A1, BCL2L11, ATF4, RAF1 | More | |
Imipramine | hsa04211 | Longevity regulating pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Imipramine | hsa04213 | Longevity regulating pathway - multiple species | 2.83E-03 | 3 | P08069, Q9Y4H2, Q13547 | IGF1R, IRS2, HDAC1 | More | |
Imipramine | hsa04217 | Necroptosis | 9.04E-10 | 19 | P01375, P01568, P48023, Q13489, P42224, Q14765, P07900, P08238, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, Q93077, Q13557, Q9H444, O43633, Q08752 | TNF, IFNA21, FASLG, BIRC3, STAT1, STAT4, HSP90AA1, HSP90AB1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, HIST1H2AC, CAMK2D, CHMP4B, CHMP2A, PPID | More | |
Imipramine | hsa04218 | Cellular senescence | 8.08E-03 | 5 | P01106, P04049, O75293, P30304, P06493 | MYC, RAF1, GADD45B, CDC25A, CDK1 | More | |
Imipramine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.95E-02 | 4 | P07550, P22694, P18848, Q13362 | ADRB2, PRKACB, ATF4, PPP2R5C | More | |
Imipramine | hsa04270 | Vascular smooth muscle contraction | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04340 | Hedgehog signaling pathway | 7.27E-04 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | |
Imipramine | hsa04360 | Axon guidance | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04370 | VEGF signaling pathway | 2.77E-04 | 4 | P16298, Q05397, Q02750, P04049 | PPP3CB, PTK2, MAP2K1, RAF1 | More | |
Imipramine | hsa04371 | Apelin signaling pathway | 2.65E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04510 | Focal adhesion | 1.18E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Imipramine | hsa04512 | ECM-receptor interaction | 4.41E-02 | 3 | Q13751, P13612, O15335 | LAMB3, ITGA4, CHAD | More | |
Imipramine | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
Imipramine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
Imipramine | hsa04540 | Gap junction | 5.06E-03 | 4 | P22694, P68371, P04049, Q14643 | PRKACB, TUBB2C, RAF1, ITPR1 | More | |
Imipramine | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.61E-03 | 5 | Q13873, P04049, Q02750, P08069, Q86SE9 | BMPR2, RAF1, MAP2K1, IGF1R, PCGF5 | More | |
Imipramine | hsa04610 | Complement and coagulation cascades | 1.15E-08 | 1 | P0C0L4 | C4A | More | |
Imipramine | hsa04611 | Platelet activation | 3.39E-02 | 3 | P25116, P08514, P07359 | F2R, ITGA2B, GP1BA | More | |
Imipramine | hsa04612 | Antigen processing and presentation | 1.07E-03 | 6 | Q14953, P26715, P26717, Q13241, P01732, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | |
Imipramine | hsa04613 | Neutrophil extracellular trap formation | 1.49E-11 | 24 | P04049, P11215, O60603, P05164, P08246, Q9UM07, Q13547, P04908, Q6FI13, Q93077, P58876, P62807, Q16778, O60814, P68431, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | RAF1, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P11215 | ITGAM | Integrin alpha-M | 0.706 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | O60603 | TLR2 | Toll-like receptor 2 | 0.783 | P22748 | CA4 | Carbonic anhydrase 4 | O60603 | TLR2 | Toll-like receptor 2 | 0.919 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.783 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P05164 | MPO | Myeloperoxidase | 0.897 | P22748 | CA4 | Carbonic anhydrase 4 | P05164 | MPO | Myeloperoxidase | 0.826 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P05164 | MPO | Myeloperoxidase | 0.897 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P08246 | ELA2 | Neutrophil elastase | 0.934 | P22748 | CA4 | Carbonic anhydrase 4 | P08246 | ELA2 | Neutrophil elastase | 0.921 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P08246 | ELA2 | Neutrophil elastase | 0.934 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.897 | P22748 | CA4 | Carbonic anhydrase 4 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.856 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.897 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.711 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.755 | P22748 | CA4 | Carbonic anhydrase 4 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.866 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.755 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P58876 | H2BC5 | Histone H2B type 1-D | 0.947 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q16778 | HIST2H2BE | Histone H2B type 2-E | 0.793 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.72 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.839 | P22748 | CA4 | Carbonic anhydrase 4 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.951 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.839 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P20160 | AZU1 | Azurocidin | 0.863 | P22748 | CA4 | Carbonic anhydrase 4 | P20160 | AZU1 | Azurocidin | 0.747 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P20160 | AZU1 | Azurocidin | 0.863 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P08311 | CTSG | Cathepsin G | 0.826 | P22748 | CA4 | Carbonic anhydrase 4 | P08311 | CTSG | Cathepsin G | 0.717 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P08311 | CTSG | Cathepsin G | 0.826 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.832 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.832 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.753 | P22748 | CA4 | Carbonic anhydrase 4 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.81 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.753 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.751 | P22748 | CA4 | Carbonic anhydrase 4 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.826 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.751 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.815 | P22748 | CA4 | Carbonic anhydrase 4 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.895 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.815 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P22748 | CA4 | Carbonic anhydrase 4 | O43315 | AQP9 | Aquaporin-9 | 0.771 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 | P08246 | ELA2 | Neutrophil elastase | P17252 | PRKCA | Protein kinase C alpha type | -0.735 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P11215 | ITGAM | Integrin alpha-M | 0.706 | P08246 | ELA2 | Neutrophil elastase | O60603 | TLR2 | Toll-like receptor 2 | 0.853 | P22748 | CA4 | Carbonic anhydrase 4 | O60603 | TLR2 | Toll-like receptor 2 | 0.919 | P08246 | ELA2 | Neutrophil elastase | P05164 | MPO | Myeloperoxidase | 0.903 | P22748 | CA4 | Carbonic anhydrase 4 | P05164 | MPO | Myeloperoxidase | 0.826 | P08246 | ELA2 | Neutrophil elastase | P08246 | ELA2 | Neutrophil elastase | 1 | P22748 | CA4 | Carbonic anhydrase 4 | P08246 | ELA2 | Neutrophil elastase | 0.921 | P08246 | ELA2 | Neutrophil elastase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.889 | P22748 | CA4 | Carbonic anhydrase 4 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.856 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.711 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P08246 | ELA2 | Neutrophil elastase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.907 | P22748 | CA4 | Carbonic anhydrase 4 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.866 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P58876 | H2BC5 | Histone H2B type 1-D | 0.947 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q16778 | HIST2H2BE | Histone H2B type 2-E | 0.793 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.72 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P08246 | ELA2 | Neutrophil elastase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.762 | P08246 | ELA2 | Neutrophil elastase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.945 | P22748 | CA4 | Carbonic anhydrase 4 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.951 | P08246 | ELA2 | Neutrophil elastase | P20160 | AZU1 | Azurocidin | 0.842 | P22748 | CA4 | Carbonic anhydrase 4 | P20160 | AZU1 | Azurocidin | 0.747 | P08246 | ELA2 | Neutrophil elastase | P08311 | CTSG | Cathepsin G | 0.792 | P22748 | CA4 | Carbonic anhydrase 4 | P08311 | CTSG | Cathepsin G | 0.717 | P08246 | ELA2 | Neutrophil elastase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.807 | P22748 | CA4 | Carbonic anhydrase 4 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.81 | P08246 | ELA2 | Neutrophil elastase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.703 | P22748 | CA4 | Carbonic anhydrase 4 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.826 | P08246 | ELA2 | Neutrophil elastase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.85 | P22748 | CA4 | Carbonic anhydrase 4 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.895 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P22748 | CA4 | Carbonic anhydrase 4 | O43315 | AQP9 | Aquaporin-9 | 0.771 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 |
|
Imipramine | hsa04621 | NOD-like receptor signaling pathway | 2.77E-03 | 8 | Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | |
Imipramine | hsa04623 | Cytosolic DNA-sensing pathway | 3.15E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | |
Imipramine | hsa04625 | C-type lectin receptor signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04630 | JAK-STAT signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04640 | Hematopoietic cell lineage | 3.69E-02 | 4 | P21926, P07766, P01730, P09564 | CD9, CD3E, CD4, CD7 | More | |
Imipramine | hsa04650 | Natural killer cell mediated cytotoxicity | 4.89E-07 | 13 | P16298, P50591, P01375, P17252, O60880, P20963, Q02750, P04049, Q13241, P26718, P26717, Q14953, P26715 | PPP3CB, TNFSF10, TNF, PRKCA, SH2D1A, CD247, MAP2K1, RAF1, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1 | More | |
Imipramine | hsa04657 | IL-17 signaling pathway | 5.66E-05 | 10 | P07900, O00463, Q16539, P49841, P19875, P14780, Q9UJX4, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL2, MMP9, ANAPC5, LCN2, TNF, IL1B | More | |
Imipramine | hsa04660 | T cell receptor signaling pathway | 1.66E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04662 | B cell receptor signaling pathway | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04664 | Fc epsilon RI signaling pathway | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04666 | Fc gamma R-mediated phagocytosis | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04668 | TNF signaling pathway | 2.67E-03 | 6 | P01375, P18848, P19875, P01584, P14780, P20333 | TNF, ATF4, CXCL2, IL1B, MMP9, TNFRSF1B | More | |
Imipramine | hsa04672 | Intestinal immune network for IgA production | 1.35E-02 | 2 | P29965, P13765 | CD40LG, HLA-DOB | More | |
Imipramine | hsa04713 | Circadian entrainment | 1.69E-02 | 3 | P17252, P48058, P22694 | PRKCA, GRIA4, PRKACB | More | |
Imipramine | hsa04714 | Thermogenesis | 4.53E-04 | 5 | P22694, Q16539, P33121, Q16718, O14521 | PRKACB, MAPK14, ACSL1, NDUFA5, SDHD | More | |
Imipramine | hsa04720 | Long-term potentiation | 4.88E-03 | 4 | P16298, P51812, Q02750, P04049 | PPP3CB, RPS6KA3, MAP2K1, RAF1 | More | |
Imipramine | hsa04721 | Synaptic vesicle cycle | 6.59E-04 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | |
Imipramine | hsa04722 | Neurotrophin signaling pathway | 7.10E-03 | 4 | P04049, P49841, O43524, P48023 | RAF1, GSK3B, FOXO3, FASLG | More | |
Imipramine | hsa04723 | Retrograde endocannabinoid signaling | 1.20E-03 | 4 | P17252, P48058, P22694, Q16718 | PRKCA, GRIA4, PRKACB, NDUFA5 | More | |
Imipramine | hsa04724 | Glutamatergic synapse | 3.36E-04 | 7 | P48058, O15399, P22694, P17252, P63218, P50151, P15104 | GRIA4, GRIN2D, PRKACB, PRKCA, GNG5, GNG10, GLUL | More | |
Imipramine | hsa04725 | Cholinergic synapse | 3.74E-02 | 3 | P22694, Q14643, P10415 | PRKACB, ITPR1, BCL2 | More | |
Imipramine | hsa04726 | Serotonergic synapse | 2.69E-03 | 4 | P22694, P17252, P31645, P04049 | PRKACB, PRKCA, SLC6A4, RAF1 | More | |
Imipramine | hsa04727 | GABAergic synapse | 2.44E-03 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | |
Imipramine | hsa04730 | Long-term depression | 2.64E-03 | 4 | Q14344, P08069, P04049, P07948 | GNA13, IGF1R, RAF1, LYN | More | |
Imipramine | hsa04740 | Olfactory transduction | 2.52E-02 | 1 | Q9H255 | OR51E2 | More | |
Imipramine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | |
Imipramine | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04910 | Insulin signaling pathway | 2.51E-03 | 4 | P22694, P06737, P04049, P49841 | PRKACB, PYGL, RAF1, GSK3B | More | |
Imipramine | hsa04911 | Insulin secretion | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | |
Imipramine | hsa04912 | GnRH signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04913 | Ovarian steroidogenesis | 2.13E-05 | 3 | P42330, P22694, P08069 | AKR1C3, PRKACB, IGF1R | More | |
Imipramine | hsa04914 | Progesterone-mediated oocyte maturation | 2.97E-04 | 6 | P08069, Q17RY0, Q9Y6D9, P51812, Q02750, P04049 | IGF1R, CPEB4, MAD1L1, RPS6KA3, MAP2K1, RAF1 | More | |
Imipramine | hsa04915 | Estrogen signaling pathway | 2.99E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04916 | Melanogenesis | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04917 | Prolactin signaling pathway | 6.63E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04918 | Thyroid hormone synthesis | 1.94E-03 | 3 | P22694, P17252, P27824 | PRKACB, PRKCA, CANX | More | |
Imipramine | hsa04919 | Thyroid hormone signaling pathway | 6.83E-04 | 5 | P49841, P04049, P22694, O60244, Q9NVC6 | GSK3B, RAF1, PRKACB, MED14, MED17 | More | |
Imipramine | hsa04921 | Oxytocin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04924 | Renin secretion | 2.90E-04 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | |
Imipramine | hsa04925 | Aldosterone synthesis and secretion | 9.86E-03 | 3 | P17252, P22694, P20020 | PRKCA, PRKACB, ATP2B1 | More | |
Imipramine | hsa04926 | Relaxin signaling pathway | 6.24E-03 | 5 | P18848, P22694, P14780, P04049, P30679 | ATF4, PRKACB, MMP9, RAF1, GNA15 | More | |
Imipramine | hsa04927 | Cortisol synthesis and secretion | 1.27E-03 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | |
Imipramine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.75E-03 | 5 | Q14643, P22694, P23771, P04049, P10415 | ITPR1, PRKACB, GATA3, RAF1, BCL2 | More | |
Imipramine | hsa04929 | GnRH secretion | 4.98E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | |
Imipramine | hsa04932 | Non-alcoholic fatty liver disease | 4.65E-07 | 11 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, O15239, Q16718, O14521 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, NDUFA1, NDUFA5, SDHD | More | |
Imipramine | hsa04934 | Cushing syndrome | 4.74E-02 | 3 | Q14643, P22694, P04628 | ITPR1, PRKACB, WNT1 | More | |
Imipramine | hsa04935 | Growth hormone synthesis, secretion and action | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Imipramine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 9.85E-05 | 3 | P20020, P17252, P22694 | ATP2B1, PRKCA, PRKACB | More | |
Imipramine | hsa04962 | Vasopressin-regulated water reabsorption | 6.61E-03 | 2 | P22694, Q13561 | PRKACB, DCTN2 | More | |
Imipramine | hsa04964 | Proximal tubule bicarbonate reclamation | 2.17E-03 | 1 | P00918 | CA2 | More | |
Imipramine | hsa04966 | Collecting duct acid secretion | 9.41E-05 | 2 | P02730, P00918 | SLC4A1, CA2 | More | |
Imipramine | hsa04970 | Salivary secretion | 2.08E-05 | 6 | P07550, P22694, Q14643, P20020, P17252, P49913 | ADRB2, PRKACB, ITPR1, ATP2B1, PRKCA, CAMP | More | |
Imipramine | hsa04972 | Pancreatic secretion | 6.57E-05 | 4 | P20020, P17252, Q08828, P62491 | ATP2B1, PRKCA, ADCY1, RAB11A | More | |
Imipramine | hsa04976 | Bile secretion | 1.16E-04 | 3 | O43315, P22694, P08183 | AQP9, PRKACB, ABCB1 | More | |
Imipramine | hsa05010 | Alzheimer disease | 1.12E-04 | 18 | O15239, P13073, O15399, Q9NZJ5, O75460, P0DP24, Q13564, P01584, P18848, Q71U36, O15169, P67870, P09603, P05141, P12236, P21796, P28070, P43686 | NDUFA1, COX4I1, GRIN2D, EIF2AK3, ERN1, CALM2, APPBP1, IL1B, ATF4, TUBA1A, AXIN1, CSNK2B, CSF1, SLC25A5, SLC25A6, VDAC1, PSMB4, PSMC4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.753 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.839 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | -0.707 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9NZJ5 | EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 0.728 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13564 | APPBP1 | NEDD8-activating enzyme E1 regulatory subunit | 0.873 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.742 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q71U36 | TUBA1A | Tubulin alpha-1A chain | -0.85 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15169 | AXIN1 | Axin-1 | 0.712 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.733 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.721 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.766 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.88 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.73 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | -0.707 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9NZJ5 | EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 0.728 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13564 | APPBP1 | NEDD8-activating enzyme E1 regulatory subunit | 0.873 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q71U36 | TUBA1A | Tubulin alpha-1A chain | -0.85 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.88 |
|
Imipramine | hsa05012 | Parkinson disease | 2.05E-04 | 10 | O15239, P13073, P05141, P12236, O75460, P18848, P28070, P43686, P0DP24, Q13557 | NDUFA1, COX4I1, SLC25A5, SLC25A6, ERN1, ATF4, PSMB4, PSMC4, CALM2, CAMK2D | More | |
Imipramine | hsa05016 | Huntington disease | 1.34E-05 | 10 | O15239, P13073, Q9GZM3, P24928, P30876, P62487, P52435, P05141, Q9NYC9, O75460 | NDUFA1, COX4I1, POLR2J2, POLR2A, POLR2B, POLR2G, POLR2J, SLC25A5, DNAH9, ERN1 | More | |
Imipramine | hsa05017 | Spinocerebellar ataxia | 1.29E-02 | 5 | P28070, P28074, P43686, P05141, P12236 | PSMB4, PSMB5, PSMC4, SLC25A5, SLC25A6 | More | |
Imipramine | hsa05020 | Prion disease | 1.31E-06 | 17 | P13591, P01584, P46531, P11142, O15239, Q16718, O14521, P13073, P18848, P05141, P12236, P28070, P43686, P49841, P67870, P51636, Q16539 | NCAM1, IL1B, NOTCH1, HSPA8, NDUFA1, NDUFA5, SDHD, COX4I1, ATF4, SLC25A5, SLC25A6, PSMB4, PSMC4, GSK3B, CSNK2B, CAV2, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P02768 | ALB | Albumin | P13591 | NCAM1 | Neural cell adhesion molecule 1 | 0.701 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.75 | P02768 | ALB | Albumin | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.72 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.753 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.839 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.742 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.721 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.766 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.73 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.733 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P51636 | CAV2 | Caveolin-2 | -0.75 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P02768 | ALB | Albumin | P13591 | NCAM1 | Neural cell adhesion molecule 1 | 0.701 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | P02768 | ALB | Albumin | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.72 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 |
|
Imipramine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.34E-07 | 22 | P49841, P67870, O15239, Q16718, O14521, P13073, O75460, P18848, Q13561, P48058, P05141, P12236, P17252, P20333, Q16539, O15169, P01584, Q08752, P0DP24, Q13557, P28070, P43686 | GSK3B, CSNK2B, NDUFA1, NDUFA5, SDHD, COX4I1, ERN1, ATF4, DCTN2, GRIA4, SLC25A5, SLC25A6, PRKCA, TNFRSF1B, MAPK14, AXIN1, IL1B, PPID, CALM2, CAMK2D, PSMB4, PSMC4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.733 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.753 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | -0.837 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.839 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.742 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q13561 | DCTN2 | Dynactin subunit 2 | -0.771 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q13561 | DCTN2 | Dynactin subunit 2 | 0.812 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P48058 | GRIA4 | Glutamate receptor 4 | 0.707 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.721 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.766 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P17252 | PRKCA | Protein kinase C alpha type | -0.727 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.879 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15169 | AXIN1 | Axin-1 | 0.712 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.859 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | -0.804 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.73 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q13561 | DCTN2 | Dynactin subunit 2 | -0.771 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.859 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 |
|
Imipramine | hsa05031 | Amphetamine addiction | 1.94E-03 | 5 | P48058, P22694, P18848, P17252, Q13547 | GRIA4, PRKACB, ATF4, PRKCA, HDAC1 | More | |
Imipramine | hsa05032 | Morphine addiction | 1.34E-02 | 4 | P63218, P50151, Q07343, P43250 | GNG5, GNG10, PDE4B, GRK6 | More | |
Imipramine | hsa05034 | Alcoholism | 1.81E-06 | 8 | Q13547, P04049, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, RAF1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Imipramine | hsa05100 | Bacterial invasion of epithelial cells | 1.82E-03 | 4 | Q14141, Q05397, Q92529, Q96JJ3 | SEPT6, PTK2, SHC3, ELMO2 | More | |
Imipramine | hsa05110 | Vibrio cholerae infection | 3.01E-02 | 2 | P17252, P22694 | PRKCA, PRKACB | More | |
Imipramine | hsa05131 | Shigellosis | 3.32E-03 | 9 | P01375, O00463, Q04759, Q9UDY8, Q9H1Y0, P20810, O43524, P10415, Q96A32 | TNF, TRAF5, PRKCQ, MALT1, ATG5, CAST, FOXO3, BCL2, MYLPF | More | |
Imipramine | hsa05132 | Salmonella infection | 4.98E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05133 | Pertussis | 3.47E-04 | 1 | P0C0L4 | C4A | More | |
Imipramine | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | |
Imipramine | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | |
Imipramine | hsa05140 | Leishmaniasis | 1.56E-02 | 5 | P14598, P42224, P25963, P29350, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, NCF4 | More | |
Imipramine | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | |
Imipramine | hsa05144 | Malaria | 6.73E-06 | 6 | P69905, P68871, O60603, P01375, P35443, P26718 | HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | |
Imipramine | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | |
Imipramine | hsa05150 | Staphylococcus aureus infection | 1.17E-04 | 7 | P0C0L4, P21730, P21462, O75015, P13646, P12838, P49913 | C4A, C5AR1, FPR1, FCGR3B, KRT13, DEFA4, CAMP | More | |
Imipramine | hsa05152 | Tuberculosis | 1.17E-03 | 8 | P04049, O75015, P48382, O60603, P01375, P10415, P49913, Q9UDY8 | RAF1, FCGR3B, RFX5, TLR2, TNF, BCL2, CAMP, MALT1 | More | |
Imipramine | hsa05160 | Hepatitis C | 1.40E-03 | 5 | P60033, P04049, P49841, P01375, P48023 | CD81, RAF1, GSK3B, TNF, FASLG | More | |
Imipramine | hsa05161 | Hepatitis B | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | |
Imipramine | hsa05163 | Human cytomegalovirus infection | 4.98E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05168 | Herpes simplex virus 1 infection | 3.38E-03 | 12 | P25963, P01568, Q05823, P42224, Q07955, Q13243, Q13489, Q13398, Q9HCX3, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS5, BIRC3, ZNF211, ZNF304, ZNF140, ZNF189, ZNF212 | More | |
Imipramine | hsa05170 | Human immunodeficiency virus 1 infection | 3.48E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05171 | Coronavirus disease - COVID-19 | 5.35E-08 | 18 | P01584, P23396, P62753, P25398, P62249, P42677, P40429, P36578, Q02878, P62917, P32969, P27635, Q07020, P46776, P62910, P18077, P05386, P62829 | IL1B, RPS3, RPS6, RPS12, RPS16, RPS27, RPL13A, RPL4, RPL6, RPL8, RPL9, RPL10, RPL18, RPL27A, RPL32, RPL35A, RPLP1, RPL23 | More | |
Imipramine | hsa05202 | Transcriptional misregulation in cancer | 1.25E-04 | 16 | Q15532, P41732, P14780, P27930, P14923, Q16548, P11215, Q13077, O15550, P08069, P35226, P05164, P08246, Q13547, P12980, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, ITGAM, TRAF1, UTX, IGF1R, BMI1, MPO, ELA2, HDAC1, LYL1, GADD45A | More | |
Imipramine | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | |
Imipramine | hsa05204 | Chemical carcinogenesis | 1.09E-03 | 3 | P09211, P78417, P11712 | GSTP1, GSTO1, CYP2C9 | More | |
Imipramine | hsa05205 | Proteoglycans in cancer | 3.95E-04 | 11 | Q12955, P04049, Q14247, P14780, P17252, P01375, P08069, P23588, Q13635, P22694, P08962 | ANK3, RAF1, CTTN, MMP9, PRKCA, TNF, IGF1R, EIF4B, PTCH1, PRKACB, CD63 | More | |
Imipramine | hsa05206 | MicroRNAs in cancer | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05211 | Renal cell carcinoma | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05212 | Pancreatic cancer | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05213 | Endometrial cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05214 | Glioma | 9.08E-05 | 2 | P08069, P04049 | IGF1R, RAF1 | More | |
Imipramine | hsa05215 | Prostate cancer | 1.65E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | |
Imipramine | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | |
Imipramine | hsa05218 | Melanoma | 7.23E-05 | 5 | P08069, P09619, Q9GZP0, Q02750, P04049 | IGF1R, PDGFRB, PDGFD, MAP2K1, RAF1 | More | |
Imipramine | hsa05219 | Bladder cancer | 4.98E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05220 | Chronic myeloid leukemia | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05223 | Non-small cell lung cancer | 6.95E-04 | 4 | P10826, P04049, Q9HC35, O75293 | RARB, RAF1, EML4, GADD45B | More | |
Imipramine | hsa05224 | Breast cancer | 1.47E-03 | 5 | P04049, P46531, Q9UM47, P08069, O15169 | RAF1, NOTCH1, NOTCH3, IGF1R, AXIN1 | More | |
Imipramine | hsa05225 | Hepatocellular carcinoma | 1.65E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | |
Imipramine | hsa05226 | Gastric cancer | 8.29E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05230 | Central carbon metabolism in cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Imipramine | hsa05231 | Choline metabolism in cancer | 1.49E-03 | 5 | Q02750, P04049, P09619, Q9GZP0, O15245 | MAP2K1, RAF1, PDGFRB, PDGFD, SLC22A1 | More | |
Imipramine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.21E-03 | 5 | P07766, P06239, P04049, Q9HC35, P01730 | CD3E, LCK, RAF1, EML4, CD4 | More | |
Imipramine | hsa05310 | Asthma | 1.35E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |
Imipramine | hsa05320 | Autoimmune thyroid disease | 3.16E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |
Imipramine | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | |
Imipramine | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Imipramine | hsa05330 | Allograft rejection | 1.76E-03 | 4 | P13765, P29965, P48023, P01375 | HLA-DOB, CD40LG, FASLG, TNF | More | |
Imipramine | hsa05332 | Graft-versus-host disease | 7.27E-04 | 4 | P48023, P01375, P26715, Q13241 | FASLG, TNF, KLRC1, KLRD1 | More | |
Imipramine | hsa05340 | Primary immunodeficiency | 1.28E-03 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | |
Imipramine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 3.75E-05 | 6 | Q8IZS8, P54284, P14923, P08514, P13612, Q9UJU2 | CACNA2D3, CACNB3, JUP, ITGA2B, ITGA4, LEF1 | More | |
Imipramine | hsa05414 | Dilated cardiomyopathy | 2.58E-03 | 4 | Q8IZS8, P54284, P13612, P26678 | CACNA2D3, CACNB3, ITGA4, PLN | More | |
Imipramine | hsa05415 | Diabetic cardiomyopathy | 4.88E-06 | 12 | P17252, P05141, P14598, Q15080, O15239, Q16718, O14521, P13073, Q16539, P49841, Q13557, P04406 | PRKCA, SLC25A5, NCF1, NCF4, NDUFA1, NDUFA5, SDHD, COX4I1, MAPK14, GSK3B, CAMK2D, GAPDH | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09960 | LTA4H | Leukotriene A-4 hydrolase | P17252 | PRKCA | Protein kinase C alpha type | -0.732 | P17658 | KCNA6 | Potassium voltage-gated channel subfamily A member 6 | P17252 | PRKCA | Protein kinase C alpha type | 0.707 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.798 | P17658 | KCNA6 | Potassium voltage-gated channel subfamily A member 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.738 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.758 | P17658 | KCNA6 | Potassium voltage-gated channel subfamily A member 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.723 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | -0.816 | P17658 | KCNA6 | Potassium voltage-gated channel subfamily A member 6 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.754 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P09960 | LTA4H | Leukotriene A-4 hydrolase | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | -0.799 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 0.725 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 |
|
Imipramine | hsa05416 | Viral myocarditis | 4.29E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |
Trimipramine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
Trimipramine | hsa00040 | Pentose and glucuronate interconversions | 4.00E-02 | 1 | P15121 | AKR1B1 | More | |
Trimipramine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
Trimipramine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
Trimipramine | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | |
Trimipramine | hsa00220 | Arginine biosynthesis | 1.97E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | |
Trimipramine | hsa00230 | Purine metabolism | 4.93E-02 | 1 | P21589 | NT5E | More | |
Trimipramine | hsa00240 | Pyrimidine metabolism | 3.20E-03 | 2 | P21589, P04183 | NT5E, TK1 | More | |
Trimipramine | hsa00250 | Alanine, aspartate and glutamate metabolism | 1.97E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | |
Trimipramine | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | |
Trimipramine | hsa00513 | Various types of N-glycan biosynthesis | 4.96E-02 | 1 | Q9NR34 | MAN1C1 | More | |
Trimipramine | hsa00564 | Glycerophospholipid metabolism | 4.29E-02 | 2 | Q6P1A2, P23743 | MBOAT5, DGKA | More | |
Trimipramine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
Trimipramine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Trimipramine | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
Trimipramine | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | |
Trimipramine | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.87E-03 | 3 | P06865, O15466, Q9H4F1 | HEXA, ST8SIA5, ST6GALNAC4 | More | |
Trimipramine | hsa00620 | Pyruvate metabolism | 3.90E-02 | 2 | P07195, P11766 | LDHB, ADH5 | More | |
Trimipramine | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Trimipramine | hsa00760 | Nicotinate and nicotinamide metabolism | 6.37E-04 | 1 | P21589 | NT5E | More | |
Trimipramine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Trimipramine | hsa00790 | Folate biosynthesis | 2.02E-02 | 1 | P15121 | AKR1B1 | More | |
Trimipramine | hsa00830 | Retinol metabolism | 3.15E-02 | 1 | P00325 | ADH1B | More | |
Trimipramine | hsa00910 | Nitrogen metabolism | 1.97E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | |
Trimipramine | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | |
Trimipramine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6.38E-04 | 3 | P78417, P09211, P11712 | GSTO1, GSTP1, CYP2C9 | More | |
Trimipramine | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Trimipramine | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | |
Trimipramine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | |
Trimipramine | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | |
Trimipramine | hsa01240 | Biosynthesis of cofactors | 2.52E-02 | 2 | Q9BQB6, P14550 | VKORC1, AKR1A1 | More | |
Trimipramine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa01523 | Antifolate resistance | 3.80E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | |
Trimipramine | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | |
Trimipramine | hsa03010 | Ribosome | 1.08E-04 | 11 | P62753, P25398, P32969, P40429, P62829, Q07020, P18077, P36578, P27635, P05386, P62249 | RPS6, RPS12, RPL9, RPL13A, RPL23, RPL18, RPL35A, RPL4, RPL10, RPLP1, RPS16 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P02768 | ALB | Albumin | P62753 | RPS6 | 40S ribosomal protein S6 | 0.769 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.739 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P42677 | RPS27 | 40S ribosomal protein S27 | 0.834 | P02768 | ALB | Albumin | P25398 | RPS12 | 40S ribosomal protein S12 | 0.775 | P02768 | ALB | Albumin | P32969 | RPL9 | 60S ribosomal protein L9 | 0.795 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P32969 | RPL9 | 60S ribosomal protein L9 | 0.722 | P09211 | GSTP1 | Glutathione S-transferase P | P40429 | RPL13A | 60S ribosomal protein L13a | 0.741 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P40429 | RPL13A | 60S ribosomal protein L13a | 0.825 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P62917 | RPL8 | 60S ribosomal protein L8 | 0.866 | P02768 | ALB | Albumin | P62829 | RPL23 | 60S ribosomal protein L23 | 0.757 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P46776 | RPL27A | 60S ribosomal protein L27a | 0.758 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | Q9H0U6 | MRPL18 | 39S ribosomal protein L18, mitochondrial | 0.831 | P09211 | GSTP1 | Glutathione S-transferase P | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.779 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.802 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P62910 | RPL32 | 60S ribosomal protein L32 | 0.804 | P02768 | ALB | Albumin | P18077 | RPL35A | 60S ribosomal protein L35a | 0.7 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | Q02878 | RPL6 | 60S ribosomal protein L6 | 0.819 | P02768 | ALB | Albumin | P36578 | RPL4 | 60S ribosomal protein L4 | 0.708 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P36578 | RPL4 | 60S ribosomal protein L4 | 0.823 | P09211 | GSTP1 | Glutathione S-transferase P | P27635 | RPL10 | 60S ribosomal protein L10 | 0.772 | P09211 | GSTP1 | Glutathione S-transferase P | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.707 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.881 | P09211 | GSTP1 | Glutathione S-transferase P | P62249 | RPS16 | 40S ribosomal protein S16 | 0.702 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P62249 | RPS16 | 40S ribosomal protein S16 | 0.818 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P23396 | RPS3 | 40S ribosomal protein S3 | 0.886 | P02768 | ALB | Albumin | P62753 | RPS6 | 40S ribosomal protein S6 | 0.769 | P02768 | ALB | Albumin | P25398 | RPS12 | 40S ribosomal protein S12 | 0.775 | P02768 | ALB | Albumin | P32969 | RPL9 | 60S ribosomal protein L9 | 0.795 | P09211 | GSTP1 | Glutathione S-transferase P | P40429 | RPL13A | 60S ribosomal protein L13a | 0.741 | P02768 | ALB | Albumin | P62829 | RPL23 | 60S ribosomal protein L23 | 0.757 | P09211 | GSTP1 | Glutathione S-transferase P | Q07020 | RPL18 | 60S ribosomal protein L18 | 0.779 | P02768 | ALB | Albumin | P18077 | RPL35A | 60S ribosomal protein L35a | 0.7 | P02768 | ALB | Albumin | P36578 | RPL4 | 60S ribosomal protein L4 | 0.708 | P09211 | GSTP1 | Glutathione S-transferase P | P27635 | RPL10 | 60S ribosomal protein L10 | 0.772 | P09211 | GSTP1 | Glutathione S-transferase P | P05386 | RPLP1 | 60S acidic ribosomal protein P1 | 0.707 | P09211 | GSTP1 | Glutathione S-transferase P | P62249 | RPS16 | 40S ribosomal protein S16 | 0.702 |
|
Trimipramine | hsa03013 | RNA transport | 4.92E-03 | 10 | P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | |
Trimipramine | hsa03020 | RNA polymerase | 1.27E-04 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | |
Trimipramine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | |
Trimipramine | hsa03050 | Proteasome | 1.21E-02 | 1 | P28074 | PSMB5 | More | |
Trimipramine | hsa03060 | Protein export | 4.46E-03 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | |
Trimipramine | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | |
Trimipramine | hsa03410 | Base excision repair | 2.52E-02 | 2 | P49005, P29372 | POLD2, MPG | More | |
Trimipramine | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | |
Trimipramine | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | |
Trimipramine | hsa03460 | Fanconi anemia pathway | 2.71E-02 | 1 | O94782 | USP1 | More | |
Trimipramine | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04012 | ErbB signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04014 | Ras signaling pathway | 3.65E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04015 | Rap1 signaling pathway | 3.75E-04 | 7 | P04049, P06213, P25116, Q8TEU7, O00522, P08514, P17252 | RAF1, INSR, F2R, RAPGEF6, KRIT1, ITGA2B, PRKCA | More | |
Trimipramine | hsa04022 | cGMP-PKG signaling pathway | 6.45E-03 | 5 | P04049, P18848, Q8WYR1, P05141, P0DP24 | RAF1, ATF4, PIK3R5, SLC25A5, CALM2 | More | |
Trimipramine | hsa04024 | cAMP signaling pathway | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | |
Trimipramine | hsa04062 | Chemokine signaling pathway | 3.98E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04064 | NF-kappa B signaling pathway | 1.91E-04 | 12 | P10415, Q13489, P25963, P51617, O00463, P01375, Q04759, Q9UDY8, Q13077, Q16548, Q13315, P24522 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, ATM, GADD45A | More | |
Trimipramine | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04071 | Sphingolipid signaling pathway | 1.10E-06 | 10 | P04049, P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | RAF1, PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.704 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.935 | P22748 | CA4 | Carbonic anhydrase 4 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.814 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.809 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.787 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.935 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P01375 | TNF | Tumor necrosis factor | 0.871 | P22748 | CA4 | Carbonic anhydrase 4 | P01375 | TNF | Tumor necrosis factor | 0.744 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P01375 | TNF | Tumor necrosis factor | -0.769 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P01375 | TNF | Tumor necrosis factor | 0.871 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.838 | P22748 | CA4 | Carbonic anhydrase 4 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.758 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.712 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.838 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.727 | P22748 | CA4 | Carbonic anhydrase 4 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.88 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.727 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.791 | P22748 | CA4 | Carbonic anhydrase 4 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.863 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.791 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | -0.866 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P08246 | ELA2 | Neutrophil elastase | P17252 | PRKCA | Protein kinase C alpha type | -0.735 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.704 | P08246 | ELA2 | Neutrophil elastase | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.725 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.809 | P08246 | ELA2 | Neutrophil elastase | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.797 | P22748 | CA4 | Carbonic anhydrase 4 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.814 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.787 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P22748 | CA4 | Carbonic anhydrase 4 | P01375 | TNF | Tumor necrosis factor | 0.744 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P01375 | TNF | Tumor necrosis factor | -0.769 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.712 | P08246 | ELA2 | Neutrophil elastase | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.865 | P22748 | CA4 | Carbonic anhydrase 4 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.758 | P08246 | ELA2 | Neutrophil elastase | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.847 | P22748 | CA4 | Carbonic anhydrase 4 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.88 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 | P08246 | ELA2 | Neutrophil elastase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.942 | P22748 | CA4 | Carbonic anhydrase 4 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.863 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | -0.866 |
|
Trimipramine | hsa04072 | Phospholipase D signaling pathway | 7.52E-04 | 3 | P04049, Q92529, Q14344 | RAF1, SHC3, GNA13 | More | |
Trimipramine | hsa04080 | Neuroactive ligand-receptor interaction | 1.02E-03 | 9 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21462, P21730, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, ADRB2 | More | |
Trimipramine | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | |
Trimipramine | hsa04114 | Oocyte meiosis | 6.23E-03 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | |
Trimipramine | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | |
Trimipramine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
Trimipramine | hsa04140 | Autophagy - animal | 2.82E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | |
Trimipramine | hsa04145 | Phagosome | 1.98E-02 | 8 | Q15080, P14598, Q13509, Q13488, P05164, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | |
Trimipramine | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | |
Trimipramine | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04151 | PI3K-Akt signaling pathway | 1.24E-03 | 15 | P62753, P43657, O43521, P27348, P09603, Q9GZP0, Q8WYR1, P63218, P50151, P13612, O15335, Q13751, P18848, O00141, Q6ZUJ8 | RPS6, P2RY5, BCL2L11, YWHAQ, CSF1, PDGFD, PIK3R5, GNG5, GNG10, ITGA4, CHAD, LAMB3, ATF4, SGK, PIK3AP1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.709 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.724 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P27348 | YWHAQ | 14-3-3 protein theta | 0.708 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9GZP0 | PDGFD | Platelet-derived growth factor D | 0.736 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.76 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.844 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.902 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P13612 | ITGA4 | Integrin alpha-4 | 0.77 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15335 | CHAD | Chondroadherin | -0.729 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.794 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.755 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.728 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.709 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.724 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P27348 | YWHAQ | 14-3-3 protein theta | 0.708 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9GZP0 | PDGFD | Platelet-derived growth factor D | 0.736 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.76 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.844 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.902 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P13612 | ITGA4 | Integrin alpha-4 | 0.77 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15335 | CHAD | Chondroadherin | -0.729 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.794 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.755 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.728 |
|
Trimipramine | hsa04210 | Apoptosis | 5.34E-05 | 15 | Q13315, P10415, Q13489, O76075, P25963, P01375, Q9NR28, O75460, P24522, Q16548, Q13077, O43521, P18848, Q14643, P04049 | ATM, BCL2, BIRC3, DFFB, NFKBIA, TNF, DIABLO, ERN1, GADD45A, BCL2A1, TRAF1, BCL2L11, ATF4, ITPR1, RAF1 | More | |
Trimipramine | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | |
Trimipramine | hsa04217 | Necroptosis | 8.10E-07 | 11 | P01375, P48023, Q14765, P07900, P15104, P05141, P01584, P0C0S5, Q99878, Q13557, Q9H444 | TNF, FASLG, STAT4, HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC14, CAMK2D, CHMP4B | More | |
Trimipramine | hsa04218 | Cellular senescence | 8.08E-03 | 5 | P01106, P04049, O75293, P30304, P06493 | MYC, RAF1, GADD45B, CDC25A, CDK1 | More | |
Trimipramine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.95E-02 | 4 | P07550, P22694, P18848, Q13362 | ADRB2, PRKACB, ATF4, PPP2R5C | More | |
Trimipramine | hsa04270 | Vascular smooth muscle contraction | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | |
Trimipramine | hsa04360 | Axon guidance | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04370 | VEGF signaling pathway | 2.77E-04 | 4 | P16298, Q05397, Q02750, P04049 | PPP3CB, PTK2, MAP2K1, RAF1 | More | |
Trimipramine | hsa04371 | Apelin signaling pathway | 2.65E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04512 | ECM-receptor interaction | 4.41E-02 | 3 | Q13751, P13612, O15335 | LAMB3, ITGA4, CHAD | More | |
Trimipramine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
Trimipramine | hsa04540 | Gap junction | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 9.61E-03 | 4 | Q13873, P04049, Q02750, Q86SE9 | BMPR2, RAF1, MAP2K1, PCGF5 | More | |
Trimipramine | hsa04610 | Complement and coagulation cascades | 6.23E-06 | 1 | P0C0L4 | C4A | More | |
Trimipramine | hsa04611 | Platelet activation | 3.39E-02 | 3 | P25116, P08514, P07359 | F2R, ITGA2B, GP1BA | More | |
Trimipramine | hsa04612 | Antigen processing and presentation | 1.07E-03 | 6 | Q14953, P26715, P26717, Q13241, P01732, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | |
Trimipramine | hsa04613 | Neutrophil extracellular trap formation | 1.84E-09 | 26 | P17252, P04049, P11215, O60603, P05164, P08246, Q9UM07, Q13547, P04908, Q6FI13, Q93077, P58876, P62807, Q16778, O60814, P68431, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | PRKCA, RAF1, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P11215 | ITGAM | Integrin alpha-M | 0.706 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | O60603 | TLR2 | Toll-like receptor 2 | 0.783 | P22748 | CA4 | Carbonic anhydrase 4 | O60603 | TLR2 | Toll-like receptor 2 | 0.919 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.783 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P05164 | MPO | Myeloperoxidase | 0.897 | P22748 | CA4 | Carbonic anhydrase 4 | P05164 | MPO | Myeloperoxidase | 0.826 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P05164 | MPO | Myeloperoxidase | 0.897 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P08246 | ELA2 | Neutrophil elastase | 0.934 | P22748 | CA4 | Carbonic anhydrase 4 | P08246 | ELA2 | Neutrophil elastase | 0.921 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P08246 | ELA2 | Neutrophil elastase | 0.934 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.897 | P22748 | CA4 | Carbonic anhydrase 4 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.856 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.897 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.711 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.755 | P22748 | CA4 | Carbonic anhydrase 4 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.866 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.755 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P58876 | H2BC5 | Histone H2B type 1-D | 0.947 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q16778 | HIST2H2BE | Histone H2B type 2-E | 0.793 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.72 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.839 | P22748 | CA4 | Carbonic anhydrase 4 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.951 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.839 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P20160 | AZU1 | Azurocidin | 0.863 | P22748 | CA4 | Carbonic anhydrase 4 | P20160 | AZU1 | Azurocidin | 0.747 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P20160 | AZU1 | Azurocidin | 0.863 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P08311 | CTSG | Cathepsin G | 0.826 | P22748 | CA4 | Carbonic anhydrase 4 | P08311 | CTSG | Cathepsin G | 0.717 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P08311 | CTSG | Cathepsin G | 0.826 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.832 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.832 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.753 | P22748 | CA4 | Carbonic anhydrase 4 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.81 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.753 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.751 | P22748 | CA4 | Carbonic anhydrase 4 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.826 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.751 | P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.815 | P22748 | CA4 | Carbonic anhydrase 4 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.895 | P02763 | ORM1 | Alpha-1-acid glycoprotein 1 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.815 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P22748 | CA4 | Carbonic anhydrase 4 | O43315 | AQP9 | Aquaporin-9 | 0.771 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 | P08246 | ELA2 | Neutrophil elastase | P17252 | PRKCA | Protein kinase C alpha type | -0.735 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P11215 | ITGAM | Integrin alpha-M | 0.706 | P08246 | ELA2 | Neutrophil elastase | O60603 | TLR2 | Toll-like receptor 2 | 0.853 | P22748 | CA4 | Carbonic anhydrase 4 | O60603 | TLR2 | Toll-like receptor 2 | 0.919 | P08246 | ELA2 | Neutrophil elastase | P05164 | MPO | Myeloperoxidase | 0.903 | P22748 | CA4 | Carbonic anhydrase 4 | P05164 | MPO | Myeloperoxidase | 0.826 | P08246 | ELA2 | Neutrophil elastase | P08246 | ELA2 | Neutrophil elastase | 1 | P22748 | CA4 | Carbonic anhydrase 4 | P08246 | ELA2 | Neutrophil elastase | 0.921 | P08246 | ELA2 | Neutrophil elastase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.889 | P22748 | CA4 | Carbonic anhydrase 4 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.856 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.711 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P08246 | ELA2 | Neutrophil elastase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.907 | P22748 | CA4 | Carbonic anhydrase 4 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.866 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P58876 | H2BC5 | Histone H2B type 1-D | 0.947 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q16778 | HIST2H2BE | Histone H2B type 2-E | 0.793 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.72 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P08246 | ELA2 | Neutrophil elastase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.762 | P08246 | ELA2 | Neutrophil elastase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.945 | P22748 | CA4 | Carbonic anhydrase 4 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.951 | P08246 | ELA2 | Neutrophil elastase | P20160 | AZU1 | Azurocidin | 0.842 | P22748 | CA4 | Carbonic anhydrase 4 | P20160 | AZU1 | Azurocidin | 0.747 | P08246 | ELA2 | Neutrophil elastase | P08311 | CTSG | Cathepsin G | 0.792 | P22748 | CA4 | Carbonic anhydrase 4 | P08311 | CTSG | Cathepsin G | 0.717 | P08246 | ELA2 | Neutrophil elastase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.807 | P22748 | CA4 | Carbonic anhydrase 4 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.81 | P08246 | ELA2 | Neutrophil elastase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.703 | P22748 | CA4 | Carbonic anhydrase 4 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.826 | P08246 | ELA2 | Neutrophil elastase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.85 | P22748 | CA4 | Carbonic anhydrase 4 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.895 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P22748 | CA4 | Carbonic anhydrase 4 | O43315 | AQP9 | Aquaporin-9 | 0.771 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P22748 | CA4 | Carbonic anhydrase 4 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.767 |
|
Trimipramine | hsa04621 | NOD-like receptor signaling pathway | 3.10E-03 | 11 | Q14643, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ITPR1, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | |
Trimipramine | hsa04625 | C-type lectin receptor signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04630 | JAK-STAT signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04640 | Hematopoietic cell lineage | 3.69E-02 | 4 | P21926, P07766, P01730, P09564 | CD9, CD3E, CD4, CD7 | More | |
Trimipramine | hsa04650 | Natural killer cell mediated cytotoxicity | 5.84E-06 | 11 | P16298, P50591, P01375, P20963, Q02750, P04049, Q13241, P26718, P26717, Q14953, P26715 | PPP3CB, TNFSF10, TNF, CD247, MAP2K1, RAF1, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1 | More | |
Trimipramine | hsa04657 | IL-17 signaling pathway | 5.66E-05 | 10 | P07900, O00463, Q16539, P49841, P19875, P14780, Q9UJX4, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL2, MMP9, ANAPC5, LCN2, TNF, IL1B | More | |
Trimipramine | hsa04660 | T cell receptor signaling pathway | 8.18E-03 | 8 | P01375, P25963, Q9UDY8, Q04759, P10747, O95267, Q08881, P04049 | TNF, NFKBIA, MALT1, PRKCQ, CD28, RASGRP1, ITK, RAF1 | More | |
Trimipramine | hsa04662 | B cell receptor signaling pathway | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04664 | Fc epsilon RI signaling pathway | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04666 | Fc gamma R-mediated phagocytosis | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04668 | TNF signaling pathway | 2.79E-04 | 11 | P01375, O00463, Q13489, P25963, P18848, P19875, P01584, P20749, Q13077, P14780, P20333 | TNF, TRAF5, BIRC3, NFKBIA, ATF4, CXCL2, IL1B, BCL3, TRAF1, MMP9, TNFRSF1B | More | |
Trimipramine | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | |
Trimipramine | hsa04672 | Intestinal immune network for IgA production | 1.35E-02 | 2 | P29965, P13765 | CD40LG, HLA-DOB | More | |
Trimipramine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | |
Trimipramine | hsa04720 | Long-term potentiation | 4.88E-03 | 4 | P16298, P51812, Q02750, P04049 | PPP3CB, RPS6KA3, MAP2K1, RAF1 | More | |
Trimipramine | hsa04722 | Neurotrophin signaling pathway | 7.10E-03 | 4 | P04049, P49841, O43524, P48023 | RAF1, GSK3B, FOXO3, FASLG | More | |
Trimipramine | hsa04724 | Glutamatergic synapse | 9.51E-03 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | |
Trimipramine | hsa04726 | Serotonergic synapse | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04727 | GABAergic synapse | 2.33E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | |
Trimipramine | hsa04730 | Long-term depression | 1.26E-03 | 3 | Q14344, P04049, P07948 | GNA13, RAF1, LYN | More | |
Trimipramine | hsa04740 | Olfactory transduction | 2.52E-02 | 1 | Q9H255 | OR51E2 | More | |
Trimipramine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | |
Trimipramine | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04910 | Insulin signaling pathway | 2.51E-03 | 4 | P22694, P06737, P04049, P49841 | PRKACB, PYGL, RAF1, GSK3B | More | |
Trimipramine | hsa04912 | GnRH signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04913 | Ovarian steroidogenesis | 2.45E-03 | 3 | P42330, P22694, P06213 | AKR1C3, PRKACB, INSR | More | |
Trimipramine | hsa04914 | Progesterone-mediated oocyte maturation | 1.91E-03 | 5 | Q17RY0, Q9Y6D9, P51812, Q02750, P04049 | CPEB4, MAD1L1, RPS6KA3, MAP2K1, RAF1 | More | |
Trimipramine | hsa04915 | Estrogen signaling pathway | 2.99E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04916 | Melanogenesis | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04917 | Prolactin signaling pathway | 6.63E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04918 | Thyroid hormone synthesis | 3.16E-02 | 2 | P17252, P27824 | PRKCA, CANX | More | |
Trimipramine | hsa04919 | Thyroid hormone signaling pathway | 6.83E-04 | 5 | P49841, P04049, P22694, O60244, Q9NVC6 | GSK3B, RAF1, PRKACB, MED14, MED17 | More | |
Trimipramine | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | |
Trimipramine | hsa04921 | Oxytocin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04923 | Regulation of lipolysis in adipocytes | 3.76E-02 | 1 | P06213 | INSR | More | |
Trimipramine | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | |
Trimipramine | hsa04926 | Relaxin signaling pathway | 6.24E-03 | 5 | P18848, P22694, P14780, P04049, P30679 | ATF4, PRKACB, MMP9, RAF1, GNA15 | More | |
Trimipramine | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | |
Trimipramine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04929 | GnRH secretion | 4.98E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | |
Trimipramine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | |
Trimipramine | hsa04932 | Non-alcoholic fatty liver disease | 4.65E-07 | 11 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, O15239, Q16718, O14521 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, NDUFA1, NDUFA5, SDHD | More | |
Trimipramine | hsa04935 | Growth hormone synthesis, secretion and action | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Trimipramine | hsa04960 | Aldosterone-regulated sodium reabsorption | 2.32E-03 | 2 | P06213, P48048 | INSR, KCNJ1 | More | |
Trimipramine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
Trimipramine | hsa04966 | Collecting duct acid secretion | 1.38E-03 | 2 | P02730, P00918 | SLC4A1, CA2 | More | |
Trimipramine | hsa04970 | Salivary secretion | 2.82E-03 | 5 | P07550, P22694, Q14643, P17252, P49913 | ADRB2, PRKACB, ITPR1, PRKCA, CAMP | More | |
Trimipramine | hsa04972 | Pancreatic secretion | 1.31E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | |
Trimipramine | hsa04976 | Bile secretion | 1.67E-03 | 3 | O43315, P22694, P08183 | AQP9, PRKACB, ABCB1 | More | |
Trimipramine | hsa05010 | Alzheimer disease | 4.88E-03 | 12 | P13073, O15399, Q9NZJ5, O75460, P0DP24, Q13564, P01584, P18848, Q71U36, P09603, P05141, P21796 | COX4I1, GRIN2D, EIF2AK3, ERN1, CALM2, APPBP1, IL1B, ATF4, TUBA1A, CSF1, SLC25A5, VDAC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.753 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.839 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | -0.707 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9NZJ5 | EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 0.728 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13564 | APPBP1 | NEDD8-activating enzyme E1 regulatory subunit | 0.873 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.742 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q71U36 | TUBA1A | Tubulin alpha-1A chain | -0.85 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15169 | AXIN1 | Axin-1 | 0.712 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.733 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.721 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.766 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.88 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.73 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | -0.707 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9NZJ5 | EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 0.728 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13564 | APPBP1 | NEDD8-activating enzyme E1 regulatory subunit | 0.873 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q71U36 | TUBA1A | Tubulin alpha-1A chain | -0.85 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.88 |
|
Trimipramine | hsa05012 | Parkinson disease | 2.77E-03 | 7 | O15239, P13073, P05141, O75460, P18848, P0DP24, Q13557 | NDUFA1, COX4I1, SLC25A5, ERN1, ATF4, CALM2, CAMK2D | More | |
Trimipramine | hsa05016 | Huntington disease | 4.33E-03 | 7 | O15239, P13073, P24928, P30876, P62487, P05141, O75460 | NDUFA1, COX4I1, POLR2A, POLR2B, POLR2G, SLC25A5, ERN1 | More | |
Trimipramine | hsa05017 | Spinocerebellar ataxia | 2.43E-02 | 1 | P28074 | PSMB5 | More | |
Trimipramine | hsa05020 | Prion disease | 3.73E-04 | 11 | P13591, P01584, P11142, O15239, Q16718, O14521, P13073, P18848, P05141, P49841, Q16539 | NCAM1, IL1B, HSPA8, NDUFA1, NDUFA5, SDHD, COX4I1, ATF4, SLC25A5, GSK3B, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P02768 | ALB | Albumin | P13591 | NCAM1 | Neural cell adhesion molecule 1 | 0.701 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.75 | P02768 | ALB | Albumin | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.72 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.753 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.839 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.742 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.721 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.766 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.73 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.733 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P51636 | CAV2 | Caveolin-2 | -0.75 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P02768 | ALB | Albumin | P13591 | NCAM1 | Neural cell adhesion molecule 1 | 0.701 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | P02768 | ALB | Albumin | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.72 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 |
|
Trimipramine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 9.19E-05 | 15 | P49841, O15239, Q16718, O14521, P13073, O75460, P18848, Q13561, P05141, P20333, Q16539, P01584, Q08752, P0DP24, Q13557 | GSK3B, NDUFA1, NDUFA5, SDHD, COX4I1, ERN1, ATF4, DCTN2, SLC25A5, TNFRSF1B, MAPK14, IL1B, PPID, CALM2, CAMK2D | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.733 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.753 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | -0.837 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.839 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.742 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q13561 | DCTN2 | Dynactin subunit 2 | -0.771 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q13561 | DCTN2 | Dynactin subunit 2 | 0.812 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P48058 | GRIA4 | Glutamate receptor 4 | 0.707 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.721 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.766 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P17252 | PRKCA | Protein kinase C alpha type | -0.727 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.879 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15169 | AXIN1 | Axin-1 | 0.712 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.859 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | -0.804 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.73 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q13561 | DCTN2 | Dynactin subunit 2 | -0.771 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.859 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 |
|
Trimipramine | hsa05031 | Amphetamine addiction | 4.32E-02 | 3 | P22694, P18848, Q13547 | PRKACB, ATF4, HDAC1 | More | |
Trimipramine | hsa05032 | Morphine addiction | 1.34E-02 | 4 | P63218, P50151, Q07343, P43250 | GNG5, GNG10, PDE4B, GRK6 | More | |
Trimipramine | hsa05034 | Alcoholism | 1.81E-06 | 8 | Q13547, P04049, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, RAF1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Trimipramine | hsa05100 | Bacterial invasion of epithelial cells | 2.85E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | |
Trimipramine | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | |
Trimipramine | hsa05132 | Salmonella infection | 1.81E-02 | 12 | P51617, P25963, P01375, P04049, Q9UJU2, Q13489, P10415, Q96A32, O60603, Q9BQS8, Q13561, Q13509 | IRAK1, NFKBIA, TNF, RAF1, LEF1, BIRC3, BCL2, MYLPF, TLR2, FYCO1, DCTN2, TUBB3 | More | |
Trimipramine | hsa05133 | Pertussis | 4.24E-03 | 1 | P0C0L4 | C4A | More | |
Trimipramine | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | |
Trimipramine | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | |
Trimipramine | hsa05140 | Leishmaniasis | 1.18E-02 | 7 | P14598, P13765, O60603, P25963, P01375, P51617, Q15080 | NCF1, HLA-DOB, TLR2, NFKBIA, TNF, IRAK1, NCF4 | More | |
Trimipramine | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | |
Trimipramine | hsa05144 | Malaria | 1.44E-03 | 5 | P69905, P68871, P01375, P35443, P26718 | HBA2, HBB, TNF, THBS4, KLRK1 | More | |
Trimipramine | hsa05145 | Toxoplasmosis | 3.07E-02 | 7 | P51617, P25963, P01375, P10415, Q13489, P13765, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DOB, TLR2 | More | |
Trimipramine | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | |
Trimipramine | hsa05152 | Tuberculosis | 1.41E-02 | 10 | P04049, Q13488, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617 | RAF1, TCIRG1, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | |
Trimipramine | hsa05160 | Hepatitis C | 1.40E-03 | 5 | P60033, P04049, P49841, P01375, P48023 | CD81, RAF1, GSK3B, TNF, FASLG | More | |
Trimipramine | hsa05161 | Hepatitis B | 4.82E-03 | 9 | P17252, P04049, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, RAF1, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | |
Trimipramine | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | |
Trimipramine | hsa05163 | Human cytomegalovirus infection | 4.98E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05170 | Human immunodeficiency virus 1 infection | 2.93E-04 | 14 | P04049, P01375, P17252, O00463, Q14643, P51617, P25963, O60603, Q13315, O95067, P10415, Q13619, Q93034, Q9Y6Q5 | RAF1, TNF, PRKCA, TRAF5, ITPR1, IRAK1, NFKBIA, TLR2, ATM, CCNB2, BCL2, CUL4A, CUL5, AP1M2 | More | |
Trimipramine | hsa05171 | Coronavirus disease - COVID-19 | 6.98E-05 | 12 | P01584, P62753, P25398, P62249, P40429, P36578, P32969, P27635, Q07020, P18077, P05386, P62829 | IL1B, RPS6, RPS12, RPS16, RPL13A, RPL4, RPL9, RPL10, RPL18, RPL35A, RPLP1, RPL23 | More | |
Trimipramine | hsa05202 | Transcriptional misregulation in cancer | 1.61E-06 | 20 | Q12778, Q15532, Q13315, P41732, P14780, P27930, P14923, Q16548, P11215, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, Q13547, P12980, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, ITGAM, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, HDAC1, LYL1, GADD45A | More | |
Trimipramine | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | |
Trimipramine | hsa05204 | Chemical carcinogenesis | 1.09E-03 | 3 | P09211, P78417, P11712 | GSTP1, GSTO1, CYP2C9 | More | |
Trimipramine | hsa05205 | Proteoglycans in cancer | 1.38E-03 | 10 | Q12955, P04049, Q14247, P14780, P17252, P01375, P23588, Q13635, P22694, P08962 | ANK3, RAF1, CTTN, MMP9, PRKCA, TNF, EIF4B, PTCH1, PRKACB, CD63 | More | |
Trimipramine | hsa05206 | MicroRNAs in cancer | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05211 | Renal cell carcinoma | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05212 | Pancreatic cancer | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05213 | Endometrial cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05214 | Glioma | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | |
Trimipramine | hsa05218 | Melanoma | 9.63E-04 | 4 | P09619, Q9GZP0, Q02750, P04049 | PDGFRB, PDGFD, MAP2K1, RAF1 | More | |
Trimipramine | hsa05219 | Bladder cancer | 4.98E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05220 | Chronic myeloid leukemia | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05222 | Small cell lung cancer | 2.79E-02 | 6 | Q13489, P10415, P25963, Q13077, O00463, P24522 | BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | |
Trimipramine | hsa05223 | Non-small cell lung cancer | 6.95E-04 | 4 | P10826, P04049, Q9HC35, O75293 | RARB, RAF1, EML4, GADD45B | More | |
Trimipramine | hsa05224 | Breast cancer | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05225 | Hepatocellular carcinoma | 6.30E-04 | 3 | P04049, Q92529, P51531 | RAF1, SHC3, SMARCA2 | More | |
Trimipramine | hsa05226 | Gastric cancer | 8.29E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05230 | Central carbon metabolism in cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Trimipramine | hsa05231 | Choline metabolism in cancer | 1.49E-03 | 5 | Q02750, P04049, P09619, Q9GZP0, O15245 | MAP2K1, RAF1, PDGFRB, PDGFD, SLC22A1 | More | |
Trimipramine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.21E-03 | 5 | P07766, P06239, P04049, Q9HC35, P01730 | CD3E, LCK, RAF1, EML4, CD4 | More | |
Trimipramine | hsa05310 | Asthma | 1.70E-03 | 4 | P13765, P29965, P12724, P01375 | HLA-DOB, CD40LG, RNASE3, TNF | More | |
Trimipramine | hsa05320 | Autoimmune thyroid disease | 3.16E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |
Trimipramine | hsa05321 | Inflammatory bowel disease | 7.13E-04 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | |
Trimipramine | hsa05322 | Systemic lupus erythematosus | 1.52E-05 | 14 | P08246, P08311, P09871, P01375, P10747, P13765, Q6FI13, Q93077, P58876, P62807, Q16778, O60814, P68431, P05455 | ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, SSB | More | |
Trimipramine | hsa05330 | Allograft rejection | 1.76E-03 | 4 | P13765, P29965, P48023, P01375 | HLA-DOB, CD40LG, FASLG, TNF | More | |
Trimipramine | hsa05332 | Graft-versus-host disease | 2.32E-05 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | |
Trimipramine | hsa05340 | Primary immunodeficiency | 1.28E-03 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | |
Trimipramine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.60E-04 | 6 | Q8IZS8, P54284, P14923, P08514, P13612, Q9UJU2 | CACNA2D3, CACNB3, JUP, ITGA2B, ITGA4, LEF1 | More | |
Trimipramine | hsa05414 | Dilated cardiomyopathy | 2.11E-02 | 4 | Q8IZS8, P54284, P13612, P26678 | CACNA2D3, CACNB3, ITGA4, PLN | More | |
Trimipramine | hsa05415 | Diabetic cardiomyopathy | 1.02E-03 | 8 | P05141, O15239, Q16718, O14521, P13073, Q16539, P49841, Q13557 | SLC25A5, NDUFA1, NDUFA5, SDHD, COX4I1, MAPK14, GSK3B, CAMK2D | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09960 | LTA4H | Leukotriene A-4 hydrolase | P17252 | PRKCA | Protein kinase C alpha type | -0.732 | P17658 | KCNA6 | Potassium voltage-gated channel subfamily A member 6 | P17252 | PRKCA | Protein kinase C alpha type | 0.707 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.798 | P17658 | KCNA6 | Potassium voltage-gated channel subfamily A member 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.738 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.758 | P17658 | KCNA6 | Potassium voltage-gated channel subfamily A member 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.723 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | -0.816 | P17658 | KCNA6 | Potassium voltage-gated channel subfamily A member 6 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.754 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P09960 | LTA4H | Leukotriene A-4 hydrolase | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | -0.799 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 0.725 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 |
|
Trimipramine | hsa05416 | Viral myocarditis | 4.29E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |